Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have sign...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
The Obesity and Metabolic Surgery Society of India and the Endocrine Society of India have issued their first joint cons...
As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
IASO Biotechnology has completed its acquisition of Singapore-based MediSix Therapeutics, expanding its international ce...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
Scientists at Northwestern University have found that tissue environments surrounding persistent viral reservoirs share ...
The US Food and Drug Administration has approved Moderna’s mFlusiva seasonal influenza vaccine for adults aged 50 ...
A Phase III clinical trial has found that adding high-dose vitamin D3 to chemotherapy and bevacizumab does not improve p...
Researchers at Stony Brook Cancer Center have developed an experimental RNA-based therapy that reduced non-small cell lu...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
Minoryx Therapeutics and Neuraxpharm Group have announced that the European Medicines Agency’s (EMA) Committee for...
Devonian Health Group has received Health Canada authorisation to initiate a Phase II/III paediatric clinical trial of P...
Nektar Therapeutics has initiated the first two global registrational trials in its Phase 3 ZENITH AD programme for rezp...
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals have reported positive Phase 2a data for vortosiran, an...
Alebund Pharmaceuticals has randomised and dosed the first participant in its global Phase IIb multi-regional clinical t...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
